Salesforce.com (CRM) Outperforms Broader Market: What You Need to Know

Salesforce (CRM) recently outperformed major indices, closing up 1.83% after a period of lagging its sector and the broader market. The company is poised to report earnings on September 3, 2025, with analysts projecting significant year-over-year growth: 8.2% for EPS to $2.77 and 8.66% for revenue to $10.13 billion, alongside strong full-year forecasts. Despite these growth expectations, the consensus EPS projection has remained stagnant over the past 30 days, and CRM currently holds a Zacks #3 (Hold) rank. Valuation-wise, CRM trades at a forward P/E of 22.15 and a PEG ratio of 1.72, both at a discount to its highly-ranked Computer - Software industry averages, positioning it as a potentially attractive value within its robust sector.

Analysis

Salesforce (CRM) demonstrated notable short-term strength, with its shares gaining 1.83% to close at $254.74, outpacing the S&P 500, Dow, and Nasdaq. This daily outperformance comes after a period of lagging the market, where the stock had declined 5.53% over the prior month. Market attention is now squarely focused on the company's upcoming earnings release on September 3, 2025. Analyst consensus projects solid year-over-year growth, with earnings expected to rise 8.2% to $2.77 per share and revenue to increase 8.66% to $10.13 billion. Full-year estimates are similarly robust, forecasting 10.78% EPS growth and 8.64% revenue growth. However, this positive growth outlook is tempered by the fact that the consensus EPS projection has remained stagnant over the past 30 days, contributing to a neutral Zacks Rank of #3 (Hold). From a valuation standpoint, CRM appears attractive relative to its peers, trading at a forward P/E of 22.15 and a PEG ratio of 1.72, both of which are at a discount to the industry averages of 26.33 and 1.93, respectively. This valuation is particularly noteworthy as CRM operates within the highly-ranked Computer - Software industry, which is in the top 20% of all industries tracked by Zacks.

Key Decisions for Investors

• Given the stagnant analyst estimates and a neutral Zacks #3 (Hold) rating, investors may consider holding current positions while awaiting a more definitive catalyst from the upcoming earnings report.
• For value-oriented growth investors, CRM's discounted forward P/E and PEG ratios relative to its strong industry peer group could present a compelling entry point, assuming the company meets its high-single-digit growth projections.
• The September 3rd earnings release is a critical event; any upward revision to guidance or a significant earnings beat could act as a primary trigger for a stock re-rating and a break from its recent underperformance.
• Investors should closely monitor trends in analyst estimate revisions post-earnings, as positive revisions are cited as a key correlated indicator for future stock price momentum.